Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

6.59
-0.4900-6.92%
Post-market: 6.33-0.2566-3.89%17:18 EDT
Volume:41.24K
Turnover:275.80K
Market Cap:70.33M
PE:-0.32
High:7.00
Open:6.90
Low:6.40
Close:7.08
Loading ...
Mar 26, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors